Rescue of Defective Electroretinographic Responses in Dp71-Null Mice With AAV-Mediated Reexpression of Dp71
Overview
Authors
Affiliations
Purpose: To study the potential effect of a gene therapy, designed to rescue the expression of dystrophin Dp71 in the retinas of Dp71-null mice, on retinal physiology.
Methods: We recorded electroretinograms (ERGs) in Dp71-null and wild-type littermate mice. In dark-adapted eyes, responses to flashes of several strengths were measured. In addition, flash responses on a 25-candela/square meters background were measured. On- and Off-mediated responses to sawtooth stimuli and responses to photopic sine-wave modulation (3-30 Hz) were also recorded. After establishing the ERG phenotype, the ShH10-GFP adeno-associated virus (AAV), which has been previously shown to target specifically Müller glial cells (MGCs), was delivered intravitreously with or without (sham therapy) the Dp71 coding sequence under control of a CBA promoter. ERG recordings were repeated three months after treatment. Real-time quantitative PCR and Western blotting analyses were performed in order to quantify Dp71 expression in the retinas.
Results: Dp71-null mice displayed reduced b-waves in dark- and light-adapted flash ERGs and smaller response amplitudes to photopic rapid-on sawtooth modulation and to sine-wave stimuli. Three months after intravitreal injections of the ShH10-GFP-2A-Dp71 AAV vector, ERG responses were completely recovered in treated eyes of Dp71-null mice. The functional rescue was associated with an overexpression of Dp71 in treated retinas.
Conclusions: The present results show successful functional recovery accompanying the reexpression of Dp71. In addition, this experimental model sheds light on MGCs influencing ERG components, since previous reports showed that aquaporin 4 and Kir4.1 channels were mislocated in MGCs of Dp71-null mice, while their distribution could be normalized following intravitreal delivery of the same ShH10-GFP-2A-Dp71 vector.
Vacca O, Zarrouki F, Izabelle C, Belmaati Cherkaoui M, Rendon A, Dalkara D Cells. 2024; 13(8.
PMID: 38667332 PMC: 11049308. DOI: 10.3390/cells13080718.
Dalmaso B, Liber A, Ventura D, Jancar S, Del Debbio C Front Cell Neurosci. 2024; 18:1343745.
PMID: 38572071 PMC: 10988781. DOI: 10.3389/fncel.2024.1343745.
Lagali P, Shanmugalingam U, Baker A, Mezey N, Smith P, Coupland S Doc Ophthalmol. 2023; 147(1):29-43.
PMID: 37106219 DOI: 10.1007/s10633-023-09933-y.
Gao M, Barboni M, Ventura D, Nagy B Doc Ophthalmol. 2021; 144(3):191-202.
PMID: 34559355 PMC: 9192464. DOI: 10.1007/s10633-021-09853-9.
Barboni M, Dias S, Silva L, Damico F, Vidal K, Costa M Invest Ophthalmol Vis Sci. 2021; 62(4):29.
PMID: 33891680 PMC: 8083068. DOI: 10.1167/iovs.62.4.29.